Restore EF Observational Study

CompletedOBSERVATIONAL
Enrollment

406

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

May 31, 2021

Study Completion Date

September 30, 2021

Conditions
Coronary Artery DiseaseUnstable AnginaAngina, StableNSTEMI - Non-ST Segment Elevation MI
Interventions
DEVICE

Prophylactic Impella support for a non-emergent PCI

Impella percutaneous mechanical circulatory support is placed via the femoral or axillary artery prior to a non-emergent PCI in patients at high risk for periprocedural complications including hemodynamic collapse.

Trial Locations (21)

10016

NYU Langone Medical Center, New York

23507

Sentara Healthcare, Norfolk

28275

Vidant Medical Center, Greenville

32117

Advent Health, Daytona Beach

40503

Baptist Healthcare System, Lexington

45219

Christ Hospital, Cincinnati

52803

Genesis Medical Center, Davenport

55433

Mercy Hospital, Coon Rapids

56303

St. Cloud Hospital, Saint Cloud

60076

NorthShore University HealthSystem, Skokie

70360

Lafayette General Medical Center, Houma

72117

Arkansas Cardiology P.A., North Little Rock

72703

Washington Regional Medical Center, Fayetteville

72764

Northwest Medical Center, Springdale

76011

Presbyterian Hospital Dallas, Arlington

77339

Kingwood Medical Center, Kingwood

85016

St. Joseph's Medical Center, Phoenix

85719

Tucson Medical Center, Tucson

92093

UCSD Medical Center, San Diego

92354

Loma Linda University Medical, Loma Linda

97213

Providence Portland Medical Center, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abiomed Inc.

INDUSTRY

NCT04648306 - Restore EF Observational Study | Biotech Hunter | Biotech Hunter